FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nicholas Keks

Research Profile

Disorders

Chemicals & Drugs

Activities & Behaviors

Concepts & Ideas

Co-author Network

Publications

TOP 3
Nicholas A Keks; Christine Hill; Suresh Sundram; Annette Graham; Kylee Bellingham; Brian Dean; Kenneth Opeskin; Arrigo Dorissa; David Copolov
Evaluation of treatment in 35 cases of bipolar suicide.
Nicholas A Keks; Michael Ingham; Akbar Khan; Keith Karcher
Long-acting injectable risperidone v. olanzapine tablets for schizophrenia or schizoaffective disorder. Randomised, controlled, open-label study.
Nicholas A Keks; Graham D Burrows; David Copolov; Richard Newton; Nick Paoletti; Isaac Schweitzer; John W G Tiller
Beyond the evidence: is there a place for antidepressant combinations in the pharmacotherapy of depression?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nicholas Keks (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Nicholas A Keks; Christine Hill; Suresh Sundram; Annette Graham; Kylee Bellingham; Brian Dean; Kenneth Opeskin; Arrigo Dorissa; David Copolov
Evaluation of treatment in 35 cases of bipolar suicide.
The Australian and New Zealand journal of psychiatry 2009;43(6):503-8.
2007: Nicholas A Keks; Michael Ingham; Akbar Khan; Keith Karcher
Long-acting injectable risperidone v. olanzapine tablets for schizophrenia or schizoaffective disorder. Randomised, controlled, open-label study.
The British journal of psychiatry : the journal of mental science 2007;191():131-9.
2007: Nicholas A Keks; Graham D Burrows; David Copolov; Richard Newton; Nick Paoletti; Isaac Schweitzer; John W G Tiller
Beyond the evidence: is there a place for antidepressant combinations in the pharmacotherapy of depression?
The Medical journal of Australia 2007;186(3):142-4.
2006: Rachel Wolfe; Linda Worrall-Carter; Kellie Foister; Nicholas A Keks; Vivienne Howe
Assessment of cognitive function in heart failure patients.
European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology 2006;5(2):158-64.
2006: Nicholas A Keks; Grant Blashki
The acutely psychotic patient--assessment and initial management.
Australian family physician 2006;35(3):90-4.
2006: Rajan Thomas; Vivienne Howe; Kellie Foister; Nicholas A Keks
Adjunctive lamotrigine in treatment-resistant schizophrenia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2006;9(1):125-7.
2005: Vivienne Howe; K Foister; K Jenkins; L Skene; David Copolov; Nicholas A Keks
Competence to give informed consent in acute psychosis is associated with symptoms rather than diagnosis.
Schizophrenia research 2005;77(2-3):211-4.
2005: Kathryn A Hall; Nicholas A Keks; daniel o'connor
Transdermal estrogen patches for aggressive behavior in male patients with dementia: a randomized, controlled trial.
International psychogeriatrics / IPA 2005;17(2):165-78.
2004: Grant Blashki; Nicholas A Keks; Andrew Stocky; Barbara Hocking
Managing schizophrenia in general practice.
Australian family physician 2004;33(4):221-7.
2003: Ian Freckelton; Nicholas A Keks; Vivienne Howe; Kelly Foister; Kym Jenkins; David Copolov; Danny Sullivan
How can valid informed consent be obtained from a psychotic patient for research into psychosis? Three perspectives.
Monash bioethics review 2003;22(4):60-75.
2003: Oye Gureje; Wayne Miles; Nicholas A Keks; David Grainger; Timothy Lambert; John McGrath; Pierre Tran; Stanley Catts; Allen Fraser; Harry Hustig; Scott Andersen; Ann Marie Crawford
Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New Zealand.
Schizophrenia research 2003;61(2-3):303-14.
2003: Jaya Pinikahana; Brenda Happell; Nicholas A Keks
Suicide and schizophrenia: a review of literature for the decade (1990-1999) and implications for mental health nursing.
Issues in mental health nursing 2003;24(1):27-43.
2002: Jaya Pinikahana; Brenda Happell; Mark Taylor; Nicholas A Keks
Exploring the complexity of compliance in schizophrenia.
Issues in mental health nursing 2002;23(5):513-28.
2002: Jaya Pinikahana; Brenda Happell; Judy Hope; Nicholas A Keks
Quality of life in schizophrenia: a review of the literature from 1995 to 2000.
International journal of mental health nursing 2002;11(2):103-11.
2001: Brian Dean; Geoffrey Pavey; Mark McLeod; Kenneth Opeskin; Nicholas A Keks; David Copolov
A change in the density of [(3)H]flumazenil, but not [(3)H]muscimol binding, in Brodmann's Area 9 from subjects with bipolar disorder.
Journal of affective disorders 2001;66(2-3):147-58.
2000: Nicholas A Keks; P Mazumdar; K Steele
The new antipsychotics. How much better are they?
Australian family physician 2000;29(5):445-50.
2000: Nicholas A Keks; P Mazumdar; R Shields
New developments in schizophrenia.
Australian family physician 2000;29(2):129-31, 135-6.
1999: Nicholas A Keks; K Altson; J Hope; N Krapivensky; C Culhane; A Tanaghow; P Doherty; A Bootle
Use of antipsychosis and adjunctive medications by an inner urban community psychiatric service.
The Australian and New Zealand journal of psychiatry 1999;33(6):896-901.
1999: J D Hope; Nicholas A Keks; TL Sacks; T Freer
Abnormal involuntary movements in people with schizophrenia in the community.
The Medical journal of Australia 1999;171(2):111-2.
1999: Nicholas A Keks; G D Burrows
Psychotropic drug prescribing: first the good news.
The Medical journal of Australia 1999;170(7):293-4.
1999: Nicholas A Keks; C Culhane
Risperidone (Risperdal): clinical experience with a new antipsychosis drug.
Expert opinion on investigational drugs 1999;8(4):443-52.
1999: Brian Dean; E Tomaskovic-Crook; Kenneth Opeskin; Nicholas A Keks; David Copolov
No change in the density of the serotonin1A receptor, the serotonin4 receptor or the serotonin transporter in the dorsolateral prefrontal cortex from subjects with schizophrenia.
Neurochemistry international 1999;34(2):109-15.
1998: David Copolov; W R Bell; warwick BENSON; Nicholas A Keks; D C Strazzeri; G F Johnson
Clozapine treatment in Australia: a review of haematological monitoring.
The Medical journal of Australia 1998;168(10):495-7.
1998: TL Sacks; Nicholas A Keks
Alcohol and drug dependence: diagnosis and management.
The Medical journal of Australia 1998;168(7):355-60.
1998: S B Roberts; C A Hill; Brian Dean; Nicholas A Keks; Kenneth Opeskin; David Copolov
Confirmation of the diagnosis of schizophrenia after death using DSM-IV: a Victorian experience.
The Australian and New Zealand journal of psychiatry 1998;32(1):73-6.
1998: A Davies; P C Langley; Nicholas A Keks; Stanley Catts; Timothy Lambert; Isaac Schweitzer
Risperidone versus haloperidol: II. Cost-effectiveness.
Clinical therapeutics 1998;20(1):196-213.
1998: A Davies; M A Adena; Nicholas A Keks; Stanley Catts; Timothy Lambert; Isaac Schweitzer
Risperidone versus haloperidol: I. Meta-analysis of efficacy and safety.
Clinical therapeutics 1998;20(1):58-71.
1997: P L Marzella; C Hill; Nicholas A Keks; B Singh; David Copolov
The binding of both [3H]nemonapride and [3H]raclopride is increased in schizophrenia.
Biological psychiatry 1997;42(8):648-54.
1997: Nicholas A Keks; B M Altson; TL Sacks; H H Hustig; A Tanaghow
Collaboration between general practice and community psychiatric services for people with chronic mental illness.
The Medical journal of Australia 1997;167(5):266-71.
1997: Nicholas A Keks; Graham D Burrows
The essential practice of mental health care.
The Medical journal of Australia 1997;167(3):147.
1997: David W Kissane; Sidney Bloch; Patricia Miach; Graeme C Smith; A Seddon; Nicholas A Keks
Cognitive-existential group therapy for patients with primary breast cancer--techniques and themes.
Psycho-oncology 1997;6(1):25-33.
1997: Brian Dean; Kenneth Opeskin; Geoffrey Pavey; C Hill; Nicholas A Keks
Changes in protein kinase C and adenylate cyclase in the temporal lobe from subjects with schizophrenia.
Journal of neural transmission (Vienna, Austria : 1996) 1997;104(11-12):1371-81.
1996: Kenneth Opeskin; Brian Dean; Geoffrey Pavey; C Hill; Nicholas A Keks; David Copolov
Neither protein kinase C nor adenylate cyclase are altered in the striatum from subjects with schizophrenia.
Schizophrenia research 1996;22(2):159-64.
1996: J Kulkarni; A de Castella; D Smith; J Taffe; Nicholas A Keks; David Copolov
A clinical trial of the effects of estrogen in acutely psychotic women.
Schizophrenia research 1996;20(3):247-52.
1996: C Hill; Nicholas A Keks; S Roberts; Kenneth Opeskin; B Dean; Andrew Mackinnon; David Copolov
Problem of diagnosis in postmortem brain studies of schizophrenia.
The American journal of psychiatry 1996;153(4):533-7.
1996: Brian Dean; J M Crook; Kenneth Opeskin; C Hill; Nicholas A Keks; David Copolov
The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia.
Molecular psychiatry 1996;1(1):54-8.
1996: Nicholas A Keks
Minimizing the non-extrapyramidal side-effects of antipsychotics.
Acta psychiatrica Scandinavica. Supplementum 1996;389():18-24.
1996: L Naylor; Brian Dean; Kenneth Opeskin; Geoffrey Pavey; C Hill; Nicholas A Keks; David Copolov
Changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [3H]paroxetine.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(6):749-57.
1996: Brian Dean; W Hayes; Kenneth Opeskin; L Naylor; Geoffrey Pavey; C Hill; Nicholas A Keks; David Copolov
Serotonin2 receptors and the serotonin transporter in the schizophrenic brain.
Behavioural brain research 1996;73(1-2):169-75.
1995: J Kulkarni; A de Castella; D Smith; D McKenzie; Nicholas A Keks; B Singh; David Copolov
Gonadotropin response to naloxone challenge in female and male psychotic patients: a pilot study.
Biological psychiatry 1995;38(10):701-3.
1995: Brian Dean; Kenneth Opeskin; Geoffrey Pavey; L Naylor; C Hill; Nicholas A Keks; David Copolov
[3H]paroxetine binding is altered in the hippocampus but not the frontal cortex or caudate nucleus from subjects with schizophrenia.
Journal of neurochemistry 1995;64(3):1197-202.
1995: Nicholas A Keks; David Copolov; D P McKenzie; J Kulkarni; C Hill; J D Hope; Bruce S Singh
Basal and haloperidol-stimulated prolactin and symptoms of nonaffective and affective psychoses in neuroleptic-free men.
Biological psychiatry 1995;37(4):229-34.
1994: Nicholas A Keks; J McGrath; T Lambert; S Catts; K Vaddadi; GD Burrows; F Varghese; T George; H Hustig; P Burnett
The Australian multicentre double-blind comparative study of remoxipride and thioridazine in schizophrenia.
Acta psychiatrica Scandinavica 1994;90(5):358-65.
1993: Nicholas A Keks; David Copolov; D P McKenzie; J Kulkarni; A Hassett; B Matheson; C Hill; B Mackie; B Singh; J Hirt
Growth hormone response to clonidine in neuroleptic-free patients with multidagnostically defined schizophrenia.
Psychiatry research 1993;48(1):79-90.
1992: Nicholas A Keks; D P McKenzie; L H Low; P D McGorry; C Hill; J Kulkarni; Bruce S Singh; David Copolov
Multidiagnostic evaluation of prolactin response to haloperidol challenge in schizophrenia: maximal blunting in Kraepelinian patients.
Biological psychiatry 1992;32(5):426-37.
1992: C Hill; Nicholas A Keks; H Jackson; J Kulkarni; D Hannah; David Copolov; B Singh
Symptomatic response to antipsychotics differs between recent onset and recurrent chronic schizophrenic patients.
The Australian and New Zealand journal of psychiatry 1992;26(3):417-22.
1992: J Kulkarni; M Horne; E Butler; Nicholas A Keks; David Copolov
Psychotic symptoms resulting from intraventricular infusion of dopamine in Parkinson's disease.
Biological psychiatry 1992;31(12):1225-7.
1991: Nicholas A Keks; David Copolov; B Mackie; Geoffrey W Stuart; Bruce S Singh; P D McGorry; C Coffey
Comparison of participants and nonparticipants in a neuroendocrine investigation of psychosis.
Acta psychiatrica Scandinavica 1991;83(5):373-6.
1990: J Kulkarni; Nicholas A Keks; G Stuart; B Mackie; Harry Minas; Bruce S Singh; David Copolov
Relationship of psychotic symptoms to haloperidol-stimulated prolactin release.
Acta psychiatrica Scandinavica 1990;82(4):271-4.
1990: Nicholas A Keks; David Copolov; J Kulkarni; B Mackie; Bruce S Singh; P McGorry; R T Rubin; A Hassett; M McLaughlin; R van Riel
Basal and haloperidol-stimulated prolactin in neuroleptic-free men with schizophrenia defined by 11 diagnostic systems.
Biological psychiatry 1990;27(11):1203-15.
1990: David Copolov; Nicholas A Keks; J Kulkarni; Bruce S Singh; D McKenzie; P McGorry; C Hill
Prolactin response to low-dose haloperidol challenge in schizophrenic, non-schizophrenic psychotic, and control subjects.
Psychoneuroendocrinology 1990;15(3):225-31.
1989: David Copolov; P D McGorry; Nicholas A Keks; Harry Minas; Helen Herrman; Bruce S Singh
Origins and establishment of the schizophrenia research programme at Royal Park Psychiatric Hospital.
The Australian and New Zealand journal of psychiatry 1989;23(4):443-51.
1989: Nicholas A Keks; J Kulkarni; David Copolov
Treatment of schizophrenia.
The Medical journal of Australia 1989;151(8):462-7.
1987: Nicholas A Keks; David Copolov; Bruce S Singh
Abnormal prolactin response to haloperidol challenge in men with schizophrenia.
The American journal of psychiatry 1987;144(10):1335-7.